Page last updated: 2024-08-24

valsartan and Amyloid Neuropathy Type 1

valsartan has been researched along with Amyloid Neuropathy Type 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buckley, LF; Shah, AM	1

Reviews

1 review(s) available for valsartan and Amyloid Neuropathy Type 1

Article	Year
Recent advances in the treatment of chronic heart failure. F1000Research, 2019, Volume: 8 Topics: Aminobutyrates; Amyloid Neuropathies, Familial; Angiotensin Receptor Antagonists; Biomarkers; Biphenyl Compounds; Chronic Disease; Drug Combinations; Heart Failure; Hemodynamics; Humans; Iron Deficiencies; Mitral Valve Insufficiency; Monitoring, Physiologic; Sodium-Glucose Transporter 2; Tetrazoles; Treatment Outcome; Valsartan	2019

Article

Year

Recent advances in the treatment of chronic heart failure.

F1000Research, 2019, Volume: 8

Topics: Aminobutyrates; Amyloid Neuropathies, Familial; Angiotensin Receptor Antagonists; Biomarkers; Biphenyl Compounds; Chronic Disease; Drug Combinations; Heart Failure; Hemodynamics; Humans; Iron Deficiencies; Mitral Valve Insufficiency; Monitoring, Physiologic; Sodium-Glucose Transporter 2; Tetrazoles; Treatment Outcome; Valsartan

2019